Randox Liquid Cardiac Controls Recalled for N-proBNP Claim Removal
Randox Laboratories is removing N-proBNP claims from Liquid Cardiac Controls due to decreased recovery in recent lots.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II. The hazard involves a performance issue (decreased recovery) and claim removal rather than a direct physical injury or high-risk pathogen, fitting the Moderate criteria for minor labeling or performance errors.
Plain-English summary
Randox Laboratories, Limited is recalling Randox Liquid Cardiac Controls, Catalogue Number CQ5052. The recall involves the removal of claims for N-proBNP (N-Terminal Pro-Brain Natriuretic Peptide) from the product.
The action was taken due to an observed decrease in recovery for N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in recent lots. The affected units include 7,505 items distributed in the United States and various international locations.
The source text does not specify specific consumer actions beyond the recall notice itself, nor does it report any illnesses or injuries associated with the product.
The recalled product
- Product
- Randox Liquid Cardiac Controls Catalogue Number CQ5052.
- Manufacturer
- Randox Laboratories, Limited
- Affected units
- 7,505
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- 4247CK (Exp. 28Nov2019)
- 4261CK (Exp. 28Nov2019)
- 4312CK Exp. 28Jun2020) and 4315CK (Exp. 28Jun2020)
Distribution
Part of a larger recall action
This product is one of 3 recalled by Randox Laboratories, Limited under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Randox Laboratories, Limited
See all →- HighRandox Lipoprotein (a) Diagnostic Assay Lacks FDA Clearance, Recalled
FDA (Devices) · 2025-01-29
- HighRandox Lipoprotein (a) assay distributed without required FDA clearance
FDA (Devices) · 2025-01-29
- ModerateRandox RX Daytona Plus Clinical Chemistry Analyzer Software Recall
FDA (Devices) · 2020-03-04
- ModerateRandox Liquid Cardiac Controls Recalled for N-proBNP Claim Removal
FDA (Devices) · 2019-11-27
- ModerateRandox Liquid Cardiac Controls Recalled for N-proBNP Claim Removal
FDA (Devices) · 2019-11-27
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02